戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 n the hospital had no clear association with secondary transmission.
2 myloidosis in APP transgenic hosts following secondary transmission.
3  was not conserved in wild-type mice or upon secondary transmission.
4  population and highlights the potential for secondary transmission.
5 ses, and 1717 households (27.3%) experienced secondary transmission.
6 ols/childcare, to minimize risk of household secondary transmission.
7 e as a result of prolonged incubation and/or secondary transmission.
8  of transmission patterns, and assessment of secondary transmission.
9  antiretroviral therapy discontinuation, and secondary transmission.
10 (IRR = 2.00 (95% CI 1.89, 2.12)) caused more secondary transmissions.
11 ndividual R0 >10 generated 19% of all recent secondary transmissions.
12 ex patients, there were 12 probable cases of secondary transmission (4%; 95% confidence interval, 2 t
13                                  The rate of secondary transmission among household contacts of patie
14                    We identified no cases of secondary transmission among neonates.
15 ave been published; however, no instances of secondary transmission among solid organ transplant reci
16                      Quantitation of risk of secondary transmission, and targeting of risk reduction
17 ent human SFV infection and apparent lack of secondary transmission are associated with genetic adapt
18 considered a longer time horizon or included secondary transmission benefits.
19 consequences, risks of EVD reactivation, and secondary transmission due to viral persistence in body
20 ad upon challenge and decrease the number of secondary transmission events from vaccinated animals to
21           Using published data, we estimated secondary transmission events had HIV infection in these
22                                WGS supported secondary transmission from a vaccinated individual with
23   Nevertheless, the only documented cases of secondary transmission from recovered patients have been
24  may occur among vaccinated individuals, but secondary transmission from such individuals has not bee
25 y member has been infected are the result of secondary transmission from the index patient and not of
26 ited virus shedding explained the absence of secondary transmission from the infected contact ferret
27                              Households with secondary transmission had index cases with a median vir
28 t primary infection as a result of decreased secondary transmission (herd immunity) combined with wan
29  suggest that the dynamics of human-to-human secondary transmission in contemporary outbreaks will be
30                        The high frequency of secondary transmission in households associated with evi
31 he situation 5 weeks after the first case of secondary transmission in Italy.
32 imulate community transmission and household secondary transmission in NYC.
33 PrEP cannot on its own eliminate the risk of secondary transmission in this context.
34  case of active TB in the hotspot caused 0.5 secondary transmissions in the general community for eac
35 ction of the index case led to a decrease in secondary transmission (IRR 0.75 95% CI 0.63-0.91) while
36                            Probable cases of secondary transmission occurred in 6 of 26 clusters (23%
37 scent body fluids contain Ebola virus and if secondary transmission occurs during convalescence.
38      This case report highlights the risk of secondary transmission of HIV during cessation of treatm
39                                              Secondary transmission of Oka VZV from vaccine recipient
40  July, 2021 from the eight schools included, secondary transmission of SARS-CoV-2 was not detected in
41 10 persons reported general good health, and secondary transmission of SFV was not observed in three
42  codon-129 genotype, could be susceptible to secondary transmission of vCJD through routes such as bl
43                         However, primary and secondary transmissions of BSE and vCJD in guinea pigs r
44  (maternally derived) and active (induced by secondary transmission or vaccination) immunity.
45  regarding the effect of HIV patient care on secondary transmission, routine HIV screening in a popul
46 n the Gulu district of northern Uganda, with secondary transmission to other districts.
47 ed by human transmission to 3 sow farms with secondary transmission to other pig farms, mainly throug
48                                 In contrast, secondary transmission to previously negative household
49                                              Secondary transmission to spouses has not been seen, sug
50 nsmission to injection drug users (IDUs) and secondary transmission to their sexual partners and chil
51 assumptions about the effect of screening on secondary transmission varied from favorable to unfavora
52 tics of cases in households that experienced secondary transmission versus those that did not.
53 nately impacted the rural population: 99% of secondary transmission was attributed to only 19% of inf
54                             When considering secondary transmissions, we estimated that a 1-year paus
55                            Probable cases of secondary transmission were identified on the basis of r
56 re associated with greater odds of household secondary transmission, while being a healthcare worker
57 ren were identified as the largest source of secondary transmission, with family structure influencin
58          We identified 37 cases of potential secondary transmission within 14 days of a distinct inde